Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Utility and safety of robot-assisted radical cystectomy in older patients with bladder cancer.
Kumada N, Nakane K, Yamada T, Tomioka-Inagawa R, Sugino F, Namiki S, Kawase M, Kawase K, Takeuchi S, Nakai C, Kato D, Takai M, Iinuma K, Tobisawa Y, Koie T. Kumada N, et al. Minim Invasive Ther Allied Technol. 2023 Dec;32(6):307-313. doi: 10.1080/13645706.2023.2249986. Epub 2023 Aug 22. Minim Invasive Ther Allied Technol. 2023. PMID: 37607213 Review.
Biochemical recurrence after chemohormonal therapy followed by robot-assisted radical prostatectomy in very-high-risk prostate cancer patients.
Sugino F, Nakane K, Kawase M, Ueda S, Tomioka M, Takeuchi Y, Yamada T, Namiki S, Kumada N, Kawase K, Kato D, Takai M, Iinuma K, Tobisawa Y, Ito T, Koie T. Sugino F, et al. Among authors: kumada n. J Robot Surg. 2023 Oct;17(5):2441-2449. doi: 10.1007/s11701-023-01670-3. Epub 2023 Jul 19. J Robot Surg. 2023. PMID: 37466903
Efficacy and Safety of Neoadjuvant Luteinizing Hormone-Releasing Hormone Antagonist and Tegafur-Uracil Chemohormonal Therapy for High-Risk Prostate Cancer.
Sugino F, Nakane K, Kawase M, Ueda S, Tomioka M, Takeuchi Y, Tomioka-Inagawa R, Yamada T, Namiki S, Kumada N, Takeuchi S, Kawase K, Kato D, Takai M, Iinuma K, Tobisawa Y, Koie T. Sugino F, et al. Among authors: kumada n. Life (Basel). 2023 Apr 23;13(5):1072. doi: 10.3390/life13051072. Life (Basel). 2023. PMID: 37240717 Free PMC article.
Relationship between 2nd-generation angiotensin receptor blockers and the risk of hypotension in COVID-19 patients admitted to hospital.
Yoshihara F, Matsuzawa Y, Nakatsuka K, Kirigaya J, Takeuchi I, Kimura K, Konishi M, Tamura K, Fukui K, Tsukahara K, Shimizu H, Iwabuchi K, Yamada Y, Saka K, Sato Y, Ogawa M, Hayakawa K, Ohmagari N, Ikeda S, Akao M, Shimomura H, Kihara Y, Yoshimoto A, Morita M, Kumada N, Ogata S, Nishimura K, Arisato T, Matsuo M, Kishida M, Yasuda S, Ogawa H. Yoshihara F, et al. Among authors: kumada n. Hypertens Res. 2024 Apr 26. doi: 10.1038/s41440-024-01682-y. Online ahead of print. Hypertens Res. 2024. PMID: 38664510
Emission and coherent control of Levitons in graphene.
Assouline A, Pugliese L, Chakraborti H, Lee S, Bernabeu L, Jo M, Watanabe K, Taniguchi T, Glattli DC, Kumada N, Sim HS, Parmentier FD, Roulleau P. Assouline A, et al. Among authors: kumada n. Science. 2023 Dec 15;382(6676):1260-1264. doi: 10.1126/science.adf9887. Epub 2023 Dec 14. Science. 2023. PMID: 38096376
130 results